HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23 | -99.9% | 4,210 | -40.9% | 0.00% | – |
Q3 2022 | $18,000 | -58.1% | 7,120 | -40.6% | 0.00% | – |
Q2 2022 | $43,000 | -2.3% | 11,989 | +68.4% | 0.00% | – |
Q1 2022 | $44,000 | +193.3% | 7,120 | +230.5% | 0.00% | – |
Q4 2021 | $15,000 | 0.0% | 2,154 | 0.0% | 0.00% | – |
Q3 2021 | $15,000 | -11.8% | 2,154 | 0.0% | 0.00% | – |
Q2 2021 | $17,000 | – | 2,154 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |